Addition of platinum derivatives to neoadjuvant single-agent fluoropyrimidine chemoradiotherapy in patients with stage II/III rectal cancer: protocol for a systematic review and meta-analysis (PROSPERO CRD42017073064)

BACKGROUND: Neoadjuvant (chemo-)radiation has proven to improve local control compared to surgery alone, but this improvement did not translate into better overall or disease-specific survival. The addition of oxaliplatin to fluoropyrimidine-based neoadjuvant chemoradiotherapy holds the potential of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hüttner, Felix J., Probst, Pascal, Kalkum, Eva, Hackbusch, Matthes, Jensen, Katrin, Ulrich, Alexis, Büchler, Markus W., Diener, Markus K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778669/
https://www.ncbi.nlm.nih.gov/pubmed/29357929
http://dx.doi.org/10.1186/s13643-018-0678-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778669/
https://www.ncbi.nlm.nih.gov/pubmed/29357929
http://dx.doi.org/10.1186/s13643-018-0678-9

Ejemplares similares